{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/8cf4cec7-5a0f-49c5-8ec9-36941b5c6b6e/f9dfadb2-e45f-4d26-b147-b1f64ee30fd4?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Apeiron’s Christian Angermayer: \"Magic mushrooms' long, strange trip\"","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba0b311a8cbef1d93cf121/61ba0b4a40076a0012722d87.jpg?height=200","description":"<p>The Sunday Times’ tech correspondent Danny Fortson brings on Christian Angermayer, entrepreneur and investor, to talk about magic mushrooms (4:00), why he is investing now (6:55), the lack of new drugs for mental illness (9:50), why it’s worse in the West (12:00), his first “trip” (17:10), the psilocybin company he has backed with Peter Thiel (21:55), creating a new body of clinical research (25:45), growing up in a village in Germany (27:00), starting a biotech at age 21 (28:50), selling it (30:25), investing in Hollywood (31:30), living in London (35:30), being a micro-dosing sceptic (38:30), and why backing films requires a different approach (39:35).</p>","author_name":"The Sunday Times"}